Timex Group India Reports INR 800 Cr Revenue Marks 3x Growth in Four Years DeepSeek Slashes Flagship AI Model Price by 75 in Permanent Reduction ADP Employment Data Points to Steady but Measured Labor Market Gains California Toxic Leak Emergency May Disrupt Chemical Supply Chains US Prioritizes AI Integration in China and Asia Following TrumpXi Talks Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil Prices Higher This Summer ALGS Q1 2026 Earnings NarrowerthanExpected Loss as Aligos Therapeutics Advances Pipeline NFE Q1 2026 Earnings EPS Misses Estimates as Losses Widen VPG Q1 2026 Earnings EPS Surprises Positively Amid Quiet Revenue Report Stock Gains Cango Inc Q4 2025 Earnings Deep EPS Miss Triggers Stock Decline CWST Q1 2026 Earnings Strong Earnings Beat Drives Modest Share Price Uptick TLN Q1 2026 Earnings EPS Plunges 72 Below Estimates as Energy Market Dynamics Shift Boyd Gaming BYD Shows Resilience with 173 Gain Testing Key Resistance at 8471 Amalgamated Financial Corp AMAL Shows Positive Momentum Key Levels and Market Dynamics Morgan Stanley Emerging Markets Domestic Debt Fund EDD Rises 11 as Emerging Market Debt Shows Resilience DiaMedica Therapeutics DMAC Gains 243 as Buyers Defend Key Support Invesco Quality Municipal Income Trust IQI Gains Ground as Bond Markets Stabilize EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin Yet Stock Rises 441 Kyndryl Holdings KD Gains Over 18 as Shares Approach Key Resistance Level INCY Q1 2026 Earnings Strong EPS Beat Despite Revenue Data Gap PRTH Q1 2026 Earnings EPS Beats Estimates by 277 Stock Rises WEBTOON Entertainment WBTN Q1 2026 Earnings EPS Beat Driven by Cost Controls Amid Revenue Uncertainty ERAS Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower BuzzFeed Inc BZFD Q1 2026 Earnings EPS Misses Estimates as Stock Surprises with Rally FOXF Q1 2026 Earnings EPS Surges 115 Above Estimates Stock Rises Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending